1. Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes. Issue 3 (June 2022) Authors: Mishriky, Basem M.; Cummings, Doyle M.; Powell, James R. Journal: Primary care diabetes Issue: Volume 16:Issue 3(2022) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis. Issue 10 (30th June 2019) Authors: Mishriky, Basem M.; Powell, James R.; Wittwer, Jennifer A.; Chu, Jennifer X.; Sewell, Kerry A.; Wu, Qiang; Cummings, Doyle M. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 10(2019) Page Start: 2274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials. Issue 5 (2nd February 2021) Authors: Hamedi, Zahra; Mishriky, Basem M.; Okunrintemi, Victor; Powell, James R.; Cummings, Doyle M. Journal: Diabetes/metabolism research and reviews Issue: Volume 37:Issue 5(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. Issue 6 (18th August 2019) Authors: Mendez, Carlos E.; Walker, Rebekah J.; Eiler, Christian R.; Mishriky, Basem M.; Egede, Leonard E. Journal: Postgraduate medicine Issue: Volume 131:Issue 6(2019) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?. Issue 8 (17th November 2018) Authors: Mishriky, Basem M.; Cummings, Doyle M.; Tanenberg, Robert; Pories, Walter J. Journal: Postgraduate medicine Issue: Volume 130:Issue 8(2018) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sodium‐glucose co‐transporter‐2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials. Issue 1 (19th October 2020) Authors: Okunrintemi, Victor; Mishriky, Basem M.; Powell, James R.; Cummings, Doyle M. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials. (July 2021) Authors: Younes, Ahmed M.; Mishriky, Basem M.; Powell, James R; Cummings, Doyle M Journal: Diabetes research and clinical practice Issue: Volume 177(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis. Issue 2 (August 2015) Authors: Mishriky, Basem M.; Cummings, Doyle M.; Tanenberg, Robert J. Journal: Diabetes research and clinical practice Issue: Volume 109:Issue 2(2015) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Transitioning to non-insulin therapy in a patient receiving high dose insulin. Issue 6 (June 2020) Authors: Mishriky, Basem M.; Cummings, Doyle M.; Mendez, Carlos E.; Patil, Shivajirao P.; Powell, James R. Journal: Journal of the American Association of Nurse Practitioners Issue: Volume 32:Issue 6(2020) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗